New Business Risk-Return Simulator
Stage-Gate Optimizer — Powered by Real Options
Stress-test how staged funding and strict loss-cut discipline turn uncertain new business bets into measurable Enterprise Value — before committing full capital.
Core B2B margins are under pressure, making new growth mandatory — yet traditional "all-in" R&D and venture bets frequently burn capital without delivering EBIT.
Stage-Gate Governance & Real Options: Release small early validation tranches to test real customer demand, scale proven winners, and stop weak bets early.
Capped downside, protected group EBIT, and asymmetric upside — turning value-destroying innovation budgets into positive Enterprise Value (EVA).
Capital Allocation & Downside Protection
Before vs. After: Net EVA & Portfolio ROI
Direct shift from Traditional All-In (Before) to Staged Real Options (After)
5-Year Cumulative Cash Flow (J-Curve)
Year 1 Stage-Gate prevents the deep cash trough and accelerates breakeven
Innovation Pipeline Real Options Based Management (1,000 Monte-Carlo Paths)
Synchronized Y-axis view: Probability Fan over 5 years, Final Outcome Density (μ & ±1σ), and Cumulative Density (CDF).
Time Series: Probability Fan
Final Outcome Density (μ & ±1σ)
Cumulative Density (CDF)
Analytical Breakdown (Traditional vs. Real Options)
Hide Details ▴| Portfolio Metric | Traditional All-In | Staged Real Options | Impact (Delta) |
|---|---|---|---|
| Total Capital Deployed | €100.0M | €45.6M | −€54.4M |
| Gross Value Created (PV) | €74.0M | €54.8M | −€19.2M |
| Net Enterprise Value (EVA) | −€26.0M | +€9.2M | +€35.2M |
| Portfolio ROI | −26.0% | +20.2% | +46.2 pp |
| Net Downside Loss (Failures) | €56.0M | €20.8M | −€35.2M |
| Return-Risk Asymmetry | 0.54 : 1 | 1.44 : 1 | +0.91x |